154 related articles for article (PubMed ID: 25586599)
1. The derived neutrophil/lymphocyte ratio predicts poor clinical outcome in soft tissue sarcoma patients.
Szkandera J; Gerger A; Liegl-Atzwanger B; Stotz M; Samonigg H; Friesenbichler J; Stojakovic T; Leithner A; Pichler M
Am J Surg; 2015 Jul; 210(1):111-6. PubMed ID: 25586599
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of pre-operative inflammatory response biomarkers in gastric cancer patients and the construction of a predictive model.
Deng Q; He B; Liu X; Yue J; Ying H; Pan Y; Sun H; Chen J; Wang F; Gao T; Zhang L; Wang S
J Transl Med; 2015 Feb; 13():66. PubMed ID: 25885254
[TBL] [Abstract][Full Text] [Related]
3. The elevated preoperative derived neutrophil-to-lymphocyte ratio predicts poor clinical outcome in breast cancer patients.
Krenn-Pilko S; Langsenlehner U; Stojakovic T; Pichler M; Gerger A; Kapp KS; Langsenlehner T
Tumour Biol; 2016 Jan; 37(1):361-8. PubMed ID: 26219894
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of preoperative NLR, dNLR, PLR and CRP in surgical renal cell carcinoma patients.
Hu H; Yao X; Xie X; Wu X; Zheng C; Xia W; Ma S
World J Urol; 2017 Feb; 35(2):261-270. PubMed ID: 27255479
[TBL] [Abstract][Full Text] [Related]
5. Preoperative platelet-lymphocyte ratio is superior to neutrophil-lymphocyte ratio as a prognostic factor for soft-tissue sarcoma.
Que Y; Qiu H; Li Y; Chen Y; Xiao W; Zhou Z; Zhang X
BMC Cancer; 2015 Oct; 15():648. PubMed ID: 26432433
[TBL] [Abstract][Full Text] [Related]
6. Critical evaluation of the potential prognostic value of the pretreatment-derived neutrophil-lymphocyte ratio under consideration of C-reactive protein levels in clear cell renal cell carcinoma.
Dalpiaz O; Luef T; Seles M; Stotz M; Stojakovic T; Pummer K; Zigeuner R; Hutterer GC; Pichler M
Br J Cancer; 2017 Jan; 116(1):85-90. PubMed ID: 27907929
[TBL] [Abstract][Full Text] [Related]
7. Baseline neutrophil-to-lymphocyte ratio (NLR) and derived NLR could predict overall survival in patients with advanced melanoma treated with nivolumab.
Capone M; Giannarelli D; Mallardo D; Madonna G; Festino L; Grimaldi AM; Vanella V; Simeone E; Paone M; Palmieri G; Cavalcanti E; Caracò C; Ascierto PA
J Immunother Cancer; 2018 Jul; 6(1):74. PubMed ID: 30012216
[TBL] [Abstract][Full Text] [Related]
8. The lymphocyte/monocyte ratio predicts poor clinical outcome and improves the predictive accuracy in patients with soft tissue sarcomas.
Szkandera J; Gerger A; Liegl-Atzwanger B; Absenger G; Stotz M; Friesenbichler J; Trajanoski S; Stojakovic T; Eberhard K; Leithner A; Pichler M
Int J Cancer; 2014 Jul; 135(2):362-70. PubMed ID: 24347236
[TBL] [Abstract][Full Text] [Related]
9. High neutrophil-lymphocyte ratio is not independently associated with worse survival or recurrence in patients with extremity soft tissue sarcoma.
Strong EA; Park SH; Ethun CG; Chow B; King D; Bedi M; Charlson J; Mogal H; Tsai S; Christians K; Tran TB; Poultsides G; Grignol V; Howard JH; Tseng J; Roggin KK; Chouliaras K; Votanopoulos K; Cullinan D; Fields RC; Gamblin TC; Cardona K; Clarke CN
Surgery; 2020 Oct; 168(4):760-767. PubMed ID: 32736869
[TBL] [Abstract][Full Text] [Related]
10. The elevated pre-operative plasma fibrinogen level is an independent negative prognostic factor for cancer-specific, disease-free and overall survival in soft-tissue sarcoma patients.
Szkandera J; Pichler M; Liegl-Atzwanger B; Absenger G; Stotz M; Ploner F; Stojakovic T; Samonigg H; Eberhard K; Leithner A; Gerger A
J Surg Oncol; 2014 Feb; 109(2):139-44. PubMed ID: 24122271
[TBL] [Abstract][Full Text] [Related]
11. Do the derived neutrophil to lymphocyte ratio and the neutrophil to lymphocyte ratio predict prognosis in breast cancer?
Dirican A; Kucukzeybek BB; Alacacioglu A; Kucukzeybek Y; Erten C; Varol U; Somali I; Demir L; Bayoglu IV; Yildiz Y; Akyol M; Koyuncu B; Coban E; Ulger E; Unay FC; Tarhan MO
Int J Clin Oncol; 2015 Feb; 20(1):70-81. PubMed ID: 24532163
[TBL] [Abstract][Full Text] [Related]
12. Assessment of potential predictive value of peripheral blood inflammatory indexes in 26 cases with soft tissue sarcoma treated by pazopanib: a retrospective study.
Mirili C; Paydaş S; Guney IB; Ogul A; Gokcay S; Buyuksimsek M; Yetisir AE; Karaalioglu B; Tohumcuoglu M; Seydaoglu G
Cancer Manag Res; 2019; 11():3445-3453. PubMed ID: 31114378
[TBL] [Abstract][Full Text] [Related]
13. Biological significance and prognostic relevance of peripheral blood neutrophil-to-lymphocyte ratio in soft tissue sarcoma.
Chan JY; Zhang Z; Chew W; Tan GF; Lim CL; Zhou L; Goh WL; Poon E; Somasundaram N; Selvarajan S; Sittampalam K; Chin F; Teh J; Tan MH; Soo KC; Teo M; Farid M; Quek R
Sci Rep; 2018 Aug; 8(1):11959. PubMed ID: 30097600
[TBL] [Abstract][Full Text] [Related]
14. The Derived Neutrophil-to-Lymphocyte Ratio Is an Independent Prognostic Factor in Transplantation Ineligible Patients with Multiple Myeloma.
Lee GW; Park SW; Go SI; Kim HG; Kim MK; Min CK; Kwak JY; Bae SB; Yoon SS; Lee JJ; Kim KH; Nam SH; Mun YC; Kim HJ; Bae SH; Shin HJ; Lee JH; Park JS; Jeong SH; Lee MH; Lee HS; Park KW; Lee WS; Lee SM; Lee JO; Hyun MS; Jo DY; Lim SN; Lee JH; Kim H; Cho DY; Do YR; Kim JA; Park SK; Kim JS; Kim SJ; Yi HG; Moon JH; Choi CW; Kim SH; Kim BS; Park MR; Shim H; Song MK; Kim Y; Kim K
Acta Haematol; 2018; 140(3):146-156. PubMed ID: 30253397
[TBL] [Abstract][Full Text] [Related]
15. External validation of the derived neutrophil to lymphocyte ratio as a prognostic marker on a large cohort of pancreatic cancer patients.
Szkandera J; Stotz M; Eisner F; Absenger G; Stojakovic T; Samonigg H; Kornprat P; Schaberl-Moser R; Alzoughbi W; Ress AL; Seggewies FS; Gerger A; Hoefler G; Pichler M
PLoS One; 2013; 8(11):e78225. PubMed ID: 24223776
[TBL] [Abstract][Full Text] [Related]
16. A derived neutrophil to lymphocyte ratio predicts clinical outcome in stage II and III colon cancer patients.
Absenger G; Szkandera J; Pichler M; Stotz M; Arminger F; Weissmueller M; Schaberl-Moser R; Samonigg H; Stojakovic T; Gerger A
Br J Cancer; 2013 Jul; 109(2):395-400. PubMed ID: 23820252
[TBL] [Abstract][Full Text] [Related]
17. The combined use of the neutrophil-lymphocyte ratio and C-reactive protein level as prognostic predictors in adult patients with soft tissue sarcoma.
Nakamura T; Matsumine A; Matsubara T; Asanuma K; Uchida A; Sudo A
J Surg Oncol; 2013 Dec; 108(7):481-5. PubMed ID: 24018883
[TBL] [Abstract][Full Text] [Related]
18. Neutrophil/lymphocyte ratio is associated with survival in synovial sarcoma.
García-Ortega DY; Álvarez-Cano A; Sánchez-Llamas LA; Caro-Sanchez CHS; Martínez-Said H; Luna-Ortiz K; Cuéllar-Hübbe M
Surg Oncol; 2018 Sep; 27(3):551-555. PubMed ID: 30217318
[TBL] [Abstract][Full Text] [Related]
19. Prognostic role of elevated preoperative systemic inflammatory markers in localized soft tissue sarcoma.
Li Y; Liu X; Zhang J; Yao W
Cancer Biomark; 2016; 16(3):333-42. PubMed ID: 26835589
[TBL] [Abstract][Full Text] [Related]
20. Validation of the pretreatment derived neutrophil-lymphocyte ratio as a prognostic factor in a European cohort of patients with upper tract urothelial carcinoma.
Dalpiaz O; Pichler M; Mannweiler S; Martín Hernández JM; Stojakovic T; Pummer K; Zigeuner R; Hutterer GC
Br J Cancer; 2014 May; 110(10):2531-6. PubMed ID: 24691424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
